Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...